Article
Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle
14 Feb 2020
Abstract excerpt
Background Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant disease and has the worst prognosis and survival rate. TUBA1C is a microtubule component implicated with multiple cancers. However, the clinical significance and biological functions of TUBA1C in the progression of PDAC remain unexplored. Methods The Cancer Genome Atlas (TCGA) and Gene Expression Profiling Interactive Analysis (GEPIA) data...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
